3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Unknown
2
Completed
2
Sponsor Class
OTHER
12
INDUSTRY
4
OTHER_GOV
2
NIH
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Oesophagogastric Cancer
1
Breast Neoplasms
1
Interventions
apatinib
25
Cisplatin
19
Capecitabine
17
Irinotecan
16
Cyclophosphamide
16
fludarabine
14
Radiotherapy
12
Oxaliplatin
12
Drug Therapy
12
camrelizumab
11
Paclitaxel
11
S 1 (combination)
10
Docetaxel
10
Carboplatin
10
Fluorouracil
9
Blood Specimen Collection
9
Bevacizumab
9
Nivolumab
8
tislelizumab
7
Radiation
7
Pemetrexed
7
Gemcitabine
7
Erlotinib Hydrochloride
7
Surgical Procedures, Operative
6
Neoadjuvant Therapy
6
Albumin-Bound Paclitaxel
6
toripalimab
5
anlotinib
5
XELOX
5
Tamoxifen
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
OTHER_GOV
×
Lapatinib
×
Clear all
NCT00450203
2016-12-01
ST03
Medical Research Council
Phase 2/3
Unknown
1,103 enrolled
NCT01730677
2014-03-12
LV
National Cancer Center, Korea
Phase 2
Unknown
150 enrolled